Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease
NCT00555204
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
337
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer's Disease
Interventions
DRUG:
ABT-089
DRUG:
ABT-089
DRUG:
ABT-089
DRUG:
ABT-089
DRUG:
ABT-089
DRUG:
ABT-089
DRUG:
placebo
Sponsor
Abbott